- Home
- GMRE vs LAB Comparison
GMRE vs LAB Comparison
Compare GMRE & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMRE
- LAB
- Stock Information
- Founded
- GMRE 2011
- LAB 1999
- Country
- GMRE United States
- LAB United States
- Employees
- GMRE N/A
- LAB N/A
- Industry
- GMRE Real Estate Investment Trusts
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- GMRE Real Estate
- LAB Industrials
- Exchange
- GMRE Nasdaq
- LAB Nasdaq
- Market Cap
- GMRE 485.5M
- LAB 562.1M
- IPO Year
- GMRE N/A
- LAB 2011
- Fundamental
- Price
- GMRE $7.48
- LAB $1.16
- Analyst Decision
- GMRE Strong Buy
- LAB Buy
- Analyst Count
- GMRE 3
- LAB 2
- Target Price
- GMRE $10.88
- LAB $2.50
- AVG Volume (30 Days)
- GMRE 691.8K
- LAB 1.3M
- Earning Date
- GMRE 05-06-2025
- LAB 05-07-2025
- Dividend Yield
- GMRE 11.43%
- LAB N/A
- EPS Growth
- GMRE N/A
- LAB N/A
- EPS
- GMRE 0.01
- LAB N/A
- Revenue
- GMRE $138,760,000.00
- LAB $174,432,000.00
- Revenue This Year
- GMRE $7.89
- LAB N/A
- Revenue Next Year
- GMRE $3.13
- LAB $12.77
- P/E Ratio
- GMRE $637.54
- LAB N/A
- Revenue Growth
- GMRE N/A
- LAB 64.03
- 52 Week Low
- GMRE $6.75
- LAB $0.97
- 52 Week High
- GMRE $10.46
- LAB $2.74
- Technical
- Relative Strength Index (RSI)
- GMRE 40.89
- LAB 50.69
- Support Level
- GMRE $6.75
- LAB $0.99
- Resistance Level
- GMRE $7.68
- LAB $1.18
- Average True Range (ATR)
- GMRE 0.37
- LAB 0.10
- MACD
- GMRE -0.05
- LAB 0.01
- Stochastic Oscillator
- GMRE 34.27
- LAB 86.36
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.